FIA
PALI icon

FNY Investment Advisers’s Palisade Bio PALI Stock Holding History

FNY Investment Advisers’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17K Sell
8,500
-1,451
-15% -$2.86K 0.01% 556
2026
Q1 		$17K Hold
9,951
– – 0.01% 488
2025
Q4 		$23K Buy
+9,951
New +$19.1K 0.01% 545

Other funds holding PALI

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

FNY Investment Advisers's PALI Position: Q2 2026 in Review

FNY Investment Advisers reduced its Palisade Bio (PALI) stake by 15% in Q2 2026, selling an estimated $2.86K and leaving 8,500 shares worth $17K. The position accounts for 0.01% of the portfolio, ranked #556.

FNY Investment Advisers first reported a position in PALI in Q4 2025 and has held it in 3 quarters since. The position peaked at $23K in Q4 2025. 15 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • FNY Investment Advisers held 8,500 shares of Palisade Bio worth $17K as of Q2 2026.
  • FNY Investment Advisers sold 1,451 Palisade Bio shares in Q2 2026, an estimated $2.86K.
  • Palisade Bio made up 0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #556 holding.
  • FNY Investment Advisers first reported a position in Palisade Bio in Q4 2025 and has held it in 3 quarters since.
  • FNY Investment Advisers's Palisade Bio position peaked at $23K in Q4 2025.
  • 15 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.